Last reviewed · How we verify
MH004 0.1% Ointment
At a glance
| Generic name | MH004 0.1% Ointment |
|---|---|
| Sponsor | Minghui Pharmaceutical (Hangzhou) Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MH004 0.1% Ointment CI brief — competitive landscape report
- MH004 0.1% Ointment updates RSS · CI watch RSS
- Minghui Pharmaceutical (Hangzhou) Ltd portfolio CI